Home/Filings/4/0001415889-21-000904
4//SEC Filing

WHITE MILES D 4

Accession 0001415889-21-000904

CIK 0000001800other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 7:20 PM ET

Size

9.6 KB

Accession

0001415889-21-000904

Insider Transaction Report

Form 4
Period: 2021-02-19
WHITE MILES D
DirectorChairman and CEO
Transactions
  • Award

    Common shares without par value

    2021-02-19+44,3403,148,487 total
  • Award

    Option (right to buy)

    2021-02-19+227,272227,272 total
    Exercise: $124.04From: 2022-02-19Exp: 2031-02-18Common Shares (227,272 underlying)
  • Gift

    Common shares without par value

    2021-02-162,0003,104,147 total
Holdings
  • Common shares without par value

    (indirect: By Trust)
    35,404
Footnotes (3)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 19, 2021.
  • [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 75,757 on February 19, 2022, 75,757 on February 19, 2023, and 75,758 on February 19, 2024.

Issuer

ABBOTT LABORATORIES

CIK 0000001800

Entity typeother

Related Parties

1
  • filerCIK 0001239129

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 7:20 PM ET
Size
9.6 KB